725 Pre-clinical development of TNFR2 ligand-blocking BI-1808 for cancer immunotherapy

• Monika Semmrich,
• Linda Mårtensson,
• Ingrid Teige,
• Björn Frendeus,
• Mathilda Kovacek,
• Petra Holmkvist,
• Carolin Svensson,
• Therese Blidberg,
• Carl Roos,
• Andres McAllister,
• Mimoza Demiri,
• Marie Borggren,
• Ingrid Karlsson

Affiliations

Monika Semmrich

1BioInvent International AB, Lund, Sweden

Linda Mårtensson

1BioInvent International AB, Lund, Sweden

Ingrid Teige

1BioInvent International AB, Lund, Sweden

Björn Frendeus

1BioInvent International AB, Lund, Sweden

Mathilda Kovacek

BiInvent International, Lund, Sweden

Petra Holmkvist

BiInvent International, Lund, Sweden

Carolin Svensson

BiInvent International, Lund, Sweden

Therese Blidberg

BiInvent International, Lund, Sweden

Carl Roos

BiInvent International, Lund, Sweden

Andres McAllister

BiInvent International, Lund, Sweden

Mimoza Demiri

BiInvent International, Lund, Sweden

Marie Borggren

BiInvent International, Lund, Sweden

Ingrid Karlsson

BiInvent International, Lund, Sweden